FDA approves once-a-day inhaler from Glaxo

Home › FDA approves once-a-day inhaler from Glaxo

The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

28.06	UK economy grew more than first estimated in early 2024
28.06	K-pop agents charged with insider trading over BTS
28.06	Atlantic Tropical Weather Outlook
28.06	Eastern North Pacific Tropical Weather Outlook
28.06	USDA moves to change livestock competition rules
28.06	Nike tumbles as upstarts grab market share
28.06	Atlantic Tropical Weather Outlook
28.06	Learning to listen to nursery pigs
More »

je.st